Testing effectiveness (Phase 2)Looking for participantsNCT07565285
What this trial is testing
The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
Who this might be right for
Melanoma Stage III
Primmune Therapeutics, Inc. 48